TGFB1 and ductal breast carcinoma in situ: EMT is strongly driven by the TGFβ/Smads signaling pathway, which is activated by proteins secreted by cancer cells and DCIS-associated MECs, such as TGFβ1 and αvβ6 integrin [71,74].